Health Catalyst Inc (HCAT)

R&D Expense Growth

13.99%

Quarterly · Period ending:

HCAT logo

HCAT R&D Expense Growth

Latest reported13.99%
HCAT Quarterly R&D Growth (QoQ) (0.00% → 13.99%)
High-resolution chart · PNG

HCAT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Health Catalyst Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
13.9874%
-2.4014%
-19.2981%
-0.8957%
-18.3985%
1.2265%
5.7%
2.2256%
-6.6371%
-26.7005%
14.8356%
0.4377%
2.9739%
-12.9091%
-5.5657%
14.4479%
5.8316%
-1.8937%
6.6768%
12.8133%
1.2478%
-4.2262%
11.8596%
11.019%
-7.8469%
0.345%
-3.2203%
38.7951%
-3.1132%
-5.1037%
-2.5648%
27.713%
-2.5043%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.